Petros FG - Search Results

1

The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma.

Pletcher JP, Bhattacharjee S, Doan JP, Wynn R, Sindhwani P, Nadiminty N, Petros FG. Pletcher JP, et al. Among authors: petros fg. Front Oncol. 2021 Jul 9;11:681441. doi: 10.3389/fonc.2021.681441. eCollection 2021. Front Oncol. 2021. PMID: 34307148 Free PMC article.

2

Plasmacytoid variant of urothelial carcinoma of the bladder manifesting as bilateral ureteral and small bowel obstruction.

Carsel A, Levy C, Raghavan AM, Ortiz JA, Sindhwani P, Petros FG. Carsel A, et al. Among authors: petros fg. Urol Case Rep. 2020 Sep 16;33:101415. doi: 10.1016/j.eucr.2020.101415. eCollection 2020 Nov. Urol Case Rep. 2020. PMID: 33102112 Free PMC article.

3

Urine versus stent cultures and clinical UTIs.

Salari B, Khalid M, Ivan S, Ekwenna O, Petros F, Saltzman B, Sindhwani P. Salari B, et al. Int Urol Nephrol. 2021 Nov;53(11):2237-2242. doi: 10.1007/s11255-021-02964-x. Epub 2021 Jul 29. Int Urol Nephrol. 2021. PMID: 34327608

4

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.

Bhattacharjee S, Sullivan MJ, Wynn RR, Demagall A, Hendrix AS, Sindhwani P, Petros FG, Nadiminty N. Bhattacharjee S, et al. Among authors: petros fg. BMC Cancer. 2022 Mar 23;22(1):312. doi: 10.1186/s12885-022-09376-9. BMC Cancer. 2022. PMID: 35321693 Free PMC article.

5

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma.

Petros FG. Petros FG. Transl Androl Urol. 2020 Aug;9(4):1794-1798. doi: 10.21037/tau.2019.11.22. Transl Androl Urol. 2020. PMID: 32944542 Free PMC article. Review.

6

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes.

Ten Eyck JE, Kahlon N, Masih S, Hamouda DM, Petros FG. Ten Eyck JE, et al. Among authors: petros fg. Cancer Manag Res. 2022 Feb 22;14:729-738. doi: 10.2147/CMAR.S227323. eCollection 2022. Cancer Manag Res. 2022. PMID: 35237074 Free PMC article. Review.

7

Reply: To PMID 25892027.

Petros FG, Angell JE, Abaza R. Petros FG, et al. Urology. 2015 Jun;85(6):1359. doi: 10.1016/j.urology.2014.11.065. Epub 2015 Apr 16. Urology. 2015. PMID: 25892026 No abstract available.

8

Perinephric Hematoma and Hemorrhagic Shock as a Rare Presentation for an Acutely Obstructive Ureteral Stone with Forniceal Rupture: A Case Report.

Petros FG, Zynger DL, Box GN, Shah KK. Petros FG, et al. J Endourol Case Rep. 2016 Apr 1;2(1):74-7. doi: 10.1089/cren.2016.0033. eCollection 2016. J Endourol Case Rep. 2016. PMID: 27579423 Free PMC article.

9

Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.

Metcalfe MJ, Petros FG, Rao P, Mork ME, Xiao L, Broaddus RR, Matin SF. Metcalfe MJ, et al. Among authors: petros fg. J Urol. 2018 Jan;199(1):60-65. doi: 10.1016/j.juro.2017.08.002. Epub 2017 Aug 7. J Urol. 2018. PMID: 28797715

10

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.

D'Andrea D, Matin S, Black PC, Petros FG, Zargar H, Dinney CP, Cookson MS, Kassouf W, Dall'Era MA, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, Sridhar SS, North S, Barocas DA, Lotan Y, Stephenson AJ, van Rhijn BW, Spiess PE, Daneshmand S, Shariat SF. D'Andrea D, et al. Among authors: petros fg. BJU Int. 2021 May;127(5):528-537. doi: 10.1111/bju.15253. Epub 2020 Oct 14. BJU Int. 2021. PMID: 32981193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page